skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 18
Patent #:
9387191
Issue Dt:
07/12/2016
Application #:
13255326
Filing Dt:
09/08/2011
Publication #:
20120115945
Pub Dt:
05/10/2012
PCT #:
US1042788
Inventor:
Henry Trong Le
Title:
FERRIC CITRATE DOSAGE FORMS
Assignment: 1
Reel/Frame:
026181/0866Recorded: 04/26/2011Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
LE, HENRY TRONG
Exec Dt:
04/25/2011
Assignee:
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
20TH FLOOR
NEW YORK, NEW YORK 10022
Correspondent:
VALERIE H. BROWN
1400 WEWATTA STREET
SUITE 400
DENVER, CO 80202-5549
Assignment: 2
Reel/Frame:
027094/0971Recorded: 10/20/2011Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
LE, HENRY TRONG
Exec Dt:
10/18/2011
Assignee:
KERYX BIOPHARMACEUTICALS, INC.
750 LEXINGTON AVENUE
FLOOR 20
NEW YORK, NEW YORK 10022
Correspondent:
TIMOTHY WORRALL / DORSEY & WHITNEY LLP
1400 WEWATTA STREET
SUITE 400
DENVER, CO 80202-5549
Assignment: 3
Reel/Frame:
051119/0089Recorded: 11/26/2019Pages: 11
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
11/25/2019
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
11/25/2019
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
AKIN GUMP STRAUSS HAUER & FELD LLP
2001 K STREET N.W.
WASHINGTON, DC 20006
Assignment: 4
Reel/Frame:
052295/0662Recorded: 04/02/2020Pages: 11
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
04/01/2020
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
04/01/2020
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
AKIN GUMP STRAUSS HAUER & FELD LLP
2001 K STREET N.W.
WASHINGTON, DC 20006
Assignment: 5
Reel/Frame:
053671/0221Recorded: 09/02/2020Pages: 11
Conveyance:
SECOND AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
06/01/2020
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
06/01/2020
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET N.W.
WASHINGTON, DC 20006
Assignment: 6
Reel/Frame:
054173/0451Recorded: 09/10/2020Pages: 11
Conveyance:
THIRD AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
09/08/2020
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
09/08/2020
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET N.W.
AKIN GUMP STRAUSS HAUER & FELD LLP
WASHINGTON, DC 20006
Assignment: 7
Reel/Frame:
054793/0455Recorded: 12/17/2020Pages: 10
Conveyance:
FOURTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
12/07/2020
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
12/07/2020
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET N.W.
AKIN GUMP STRAUSS HAUER & FELD LLP
WASHINGTON, DC 20006
Assignment: 8
Reel/Frame:
055776/0491Recorded: 03/30/2021Pages: 11
Conveyance:
FIFTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
03/26/2021
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
03/26/2021
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET, N.W.
ROBERT S. STRAUSS TOWER
WASHINGTON, DC 20006
Assignment: 9
Reel/Frame:
056544/0468Recorded: 06/11/2021Pages: 11
Conveyance:
SIXTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
06/04/2021
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
06/04/2021
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET, N.W.
ROBERT S. STRAUSS TOWER
WASHINGTON, DC 20006
Assignment: 10
Reel/Frame:
057474/0770Recorded: 09/12/2021Pages: 11
Conveyance:
SEVENTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
09/03/2021
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
09/03/2021
Assignee:
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD
C/O BEAUFORT HOUSE
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
DAVID C. LEE
2001 K STREET, N.W.
ROBERT S. STRAUSS TOWER
WASHINGTON, DC 20006
Assignment: 11
Reel/Frame:
058399/0055Recorded: 12/15/2021Pages: 11
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
12/04/2021
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
12/04/2021
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
MUSSIE B BEYENE
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 12
Reel/Frame:
060529/0168Recorded: 06/16/2022Pages: 12
Conveyance:
TENTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
06/15/2022
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
06/15/2022
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
MUSSIE B BEYENE
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 13
Reel/Frame:
061297/0238Recorded: 08/22/2022Pages: 12
Conveyance:
ELEVENTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
08/22/2022
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
08/22/2022
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
MUSSIE B BEYENE
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 14
Reel/Frame:
062012/0561Recorded: 11/29/2022Pages: 12
Conveyance:
TWELFTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
11/23/2022
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
11/23/2022
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, ENGLAND AND WALES
Correspondent:
MUSSIE B BEYENE
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 15
Reel/Frame:
063189/0065Recorded: 03/29/2023Pages: 12
Conveyance:
THIRTEENTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
03/27/2023
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
03/27/2023
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
MUSSIE B BEYENE
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 16
Reel/Frame:
066205/0143Recorded: 01/04/2024Pages: 13
Conveyance:
FIFTEENTH AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
11/15/2023
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
11/15/2023
Assignee:
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD
EXETER EX4 4EP, UNITED KINGDOM
Correspondent:
AKIN GUMP STRAUSS HAUER & FELD LLP
2001 K STREET N.W.
WASHINGTON DC, DC 20006
Assignment: 17
Reel/Frame:
066377/0741Recorded: 01/29/2024Pages: 27
Conveyance:
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS
Assignor:
BIOPHARMA CREDIT PLC
Exec Dt:
01/26/2024
Assignees:
AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE, MASSACHUSETTS 02142
KERYX BIOPHARMACEUTICALS, INC.
245 FIRST STREET
CAMBRIDGE, MASSACHUSETTS 02142
Correspondent:
STEWART WALSH
1025 CONNECTICUT AVE NW, SUITE 712
COGENCY GLOBAL INC.
WASHINGTON, DC 20036
Assignment: 18
Reel/Frame:
066377/0654Recorded: 01/29/2024Pages: 16
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
AKEBIA THERAPEUTICS, INC.
Exec Dt:
01/29/2024
KERYX BIOPHARMACEUTICALS, INC.
Exec Dt:
01/29/2024
Assignee:
KREOS CAPITAL VII (UK) LIMITED
12 THROGMORTON AVENUE
C/O BLACKROCK INVESTMENT MANAGEMENT (UK) LIMITED - PRIVATE DEBT-EMEA VENTURE & GROWTH LENDING GROUP
LONDON, UNITED KINGDOM EC2N 2DL
Correspondent:
ORRICK, HERRINGTON & SUTCLIFFE LLP
2050 MAIN STREET, SUITE 1100
IRVINE, CA 92614-8255

Search Results as of: 06/21/2024 07:56 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT